ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001

Job Discrimination Survey Completed, But NCI Still Trying To Interpret I; Payments May Be Held Up

August 19, 1977

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Latest State Cancer Statistics Released.

January 14, 2005

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011